Avicanna unveils large-scale MyMedi.ca medical cannabis study

On: September 26, 2024

Image

Cannabis News
September 26, 2024

Avicanna released information on a new study through MyMedi.ca which will look into the use of medical cannabis for various health ailments such as pain, anxiety, epilepsy, sleep, and depression. In a recent press release (1), Avicanna recently announced a new study through MyMedi.ca, a medical

Medical Cannabis News

by Madeline Colli

Read More: Avicanna unveils large-scale MyMedi.ca medical cannabis study

Previous Post: Verano Holdings Corp. Set to Begin “Save the Bits” Campaign for Lynn Sage Breast Cancer Foundation

Next Post: Delaware’s cannabis industry: A secret shopper investigation finds mislabeling, contamination, and public health risks among gaps in compliance

Comments are closed, but trackbacks and pingbacks are open.